Sabe-se que um bom fluxo sanguíneo colateral (FSC) leptomeníngeo está associado a melhor desfecho funcional em paciente com oclusão vascular da circulação anterior. Entretanto, poucos estudos avaliaram os preditores de FSC e seu impacto prognósticos em países em desenvolvimento. O objetivo deste trabalho é avaliar os preditores e o impacto prognóstico do FSC leptomeníngeo nas oclusões do primeiro segmento (M1) da Artéria Cerebral Média (ACM). Métodos: Foi avaliado de maneira retrospectiva, uma coorte prospectiva de pacientes com acidente vascular cerebral (AVC), admitidos em um centro terciário acadêmico de referência para o tratamento de AVC entre janeiro de 2014 e junho de 2017. Foram incluídos pacientes que apresentavam oclusão do segmento M1 da ACM e realizaram angiotomografia de crânio (AngioTC) até 12 horas após o ictus. O FSC foi analisado utilizando uma escala previamente validada na literatura, o rLMC score. Foi avaliado a relação do rLMC score com variáveis clínicas e com desfecho. Na análise univariada foi utilizado o teste de Fisher para variáveis categóricas e t de Student para variáveis quantitativas, também foi utilizado o teste de Spearman para correlação de variáveis contínuas. Características associadas com rLMC score e com desfecho funcional foram incluídas da regressão linear (rLMC não categorizado) e regressão logística binária (rLMC categorizado). Foi utilizado um valor de significância estatística convencional (p=0,05) Resultados: Dos 1559 pacientes com AVC isquêmico admitidos, foram analisados 121 pacientes que preencheram critérios de inclusão/exclusão do estudo. A idade média foi de 67.1±15 anos, NIHSS 13 [IQR 11-22]. Na regressão linear, menor idade (? = -0.2; p=0.005), Doença de14 Chagas (? = 0,22; p=0,008), Tabagismo (? = 0,22; p=0,009), menor NIHSS (? = - 0,25; p=0,002) e história de doença coronariana (? = 0,23; p=0,005) foram associados com melhor rLMC score. Menor idade (? = 0,29; p<0,001), menor NIHSS (? = 0,36; p<0,001) e rLMC>= 17 (? = -0,16; p=0,04) foram associados com melhor desfecho clínico. Conclusão: Pacientes com bom FSC leptomeníngeo apresentam menor NIHSS, menor idade, maior frequência de doença de Chagas, história de tabagismo e doença coronariana prévia. Um bom FSC leptomeníngeo está associado a melhor desfecho funcional entre paciente com AVC isquêmico por oclusão de artérias proximais da circulação anterior no Brasil. / A Good leptomeningeal collateral flow has been associated with better outcomes in patients with proximal occlusions of the anterior circulation. Nevertheless, only few studies have assessed the predictors of good leptomeningeal collateral flow and its impact on clinical outcome in developing countries. We aim to evaluate predictors and prognostic impact of leptomeningeal collateral flow among patients with proximal middle cerebral artery (MCA) occlusion. Method: We retrospectively analyzed a prospective stroke registry of AIS patients admitted to a tertiary Stroke Center in Brazil, with MCA-M1 occlusion within twelve hours of symptoms onset, admitted from January 2014-June 2017. Leptomeningeal score was evaluated using a previously validated Regional Leptomeningeal (rLMC) score. We evaluated association between rLMC score with clinical variables and outcomes. Univariate analysis was performed using Fisher exact test for categorical variables and t-Student for continuous variables. Spearman\'s correlation analysis was performed to find the relationship between continuous variables and rLMC. Variables were included in linear regression model (non categorized rLMC) or binary logistic regression model (categorized rLMC). Conventional levels of statistical significance were used (p=0.05). Results: From 1559 AIS patients, 121 were analyzed. Demographics: age 67.1±15 years, NIHSS 13 [IQR 11-22]. In linear regression, lower age (? = -0.2; p=0.021), Chagas Disease (? = 0.22; p=0.008), smoking (? = 0.22; p=0.009), lower NIHSS (? = -0.25; p=0.002) and history of coronary artery disease (? = 0.23; p=0,005) were associated with better rLMC score. Lower age (? = 0.29; p<0.001), lower NIHSS (? = 0.36; p<0.001) and rLMC>= 17 (? = -0.16; p=0.04) were associated with better functional outcomes. Conclusion: Patients with good leptomeningeal collateral flow had lower age, lower NIHSS, Chagas disease and history of smoking. Good leptomeningeal collaterals on CT angiography are associated to good outcome among AIS patients with proximal arterial occlusion of the anterior circulation in Brazil.

Sabe-se que um bom fluxo sanguíneo colateral (FSC) leptomeníngeo está associado a melhor desfecho funcional em paciente com oclusão vascular da circulação anterior. Entretanto, poucos estudos avaliaram os preditores de FSC e seu impacto prognósticos em países em desenvolvimento. O objetivo deste trabalho é avaliar os preditores e o impacto prognóstico do FSC leptomeníngeo nas oclusões do primeiro segmento (M1) da Artéria Cerebral Média (ACM). Métodos: Foi avaliado de maneira retrospectiva, uma coorte prospectiva de pacientes com acidente vascular cerebral (AVC), admitidos em um centro terciário acadêmico de referência para o tratamento de AVC entre janeiro de 2014 e junho de 2017. Foram incluídos pacientes que apresentavam oclusão do segmento M1 da ACM e realizaram angiotomografia de crânio (AngioTC) até 12 horas após o ictus. O FSC foi analisado utilizando uma escala previamente validada na literatura, o rLMC score. Foi avaliado a relação do rLMC score com variáveis clínicas e com desfecho. Na análise univariada foi utilizado o teste de Fisher para variáveis categóricas e t de Student para variáveis quantitativas, também foi utilizado o teste de Spearman para correlação de variáveis contínuas. Características associadas com rLMC score e com desfecho funcional foram incluídas da regressão linear (rLMC não categorizado) e regressão logística binária (rLMC categorizado). Foi utilizado um valor de significância estatística convencional (p=0,05) Resultados: Dos 1559 pacientes com AVC isquêmico admitidos, foram analisados 121 pacientes que preencheram critérios de inclusão/exclusão do estudo. A idade média foi de 67.1±15 anos, NIHSS 13 [IQR 11-22]. Na regressão linear, menor idade (? = -0.2; p=0.005), Doença de14 Chagas (? = 0,22; p=0,008), Tabagismo (? = 0,22; p=0,009), menor NIHSS (? = - 0,25; p=0,002) e história de doença coronariana (? = 0,23; p=0,005) foram associados com melhor rLMC score. Menor idade (? = 0,29; p<0,001), menor NIHSS (? = 0,36; p<0,001) e rLMC>= 17 (? = -0,16; p=0,04) foram associados com melhor desfecho clínico. Conclusão: Pacientes com bom FSC leptomeníngeo apresentam menor NIHSS, menor idade, maior frequência de doença de Chagas, história de tabagismo e doença coronariana prévia. Um bom FSC leptomeníngeo está associado a melhor desfecho funcional entre paciente com AVC isquêmico por oclusão de artérias proximais da circulação anterior no Brasil. / A Good leptomeningeal collateral flow has been associated with better outcomes in patients with proximal occlusions of the anterior circulation. Nevertheless, only few studies have assessed the predictors of good leptomeningeal collateral flow and its impact on clinical outcome in developing countries. We aim to evaluate predictors and prognostic impact of leptomeningeal collateral flow among patients with proximal middle cerebral artery (MCA) occlusion. Method: We retrospectively analyzed a prospective stroke registry of AIS patients admitted to a tertiary Stroke Center in Brazil, with MCA-M1 occlusion within twelve hours of symptoms onset, admitted from January 2014-June 2017. Leptomeningeal score was evaluated using a previously validated Regional Leptomeningeal (rLMC) score. We evaluated association between rLMC score with clinical variables and outcomes. Univariate analysis was performed using Fisher exact test for categorical variables and t-Student for continuous variables. Spearman\'s correlation analysis was performed to find the relationship between continuous variables and rLMC. Variables were included in linear regression model (non categorized rLMC) or binary logistic regression model (categorized rLMC). Conventional levels of statistical significance were used (p=0.05). Results: From 1559 AIS patients, 121 were analyzed. Demographics: age 67.1±15 years, NIHSS 13 [IQR 11-22]. In linear regression, lower age (? = -0.2; p=0.021), Chagas Disease (? = 0.22; p=0.008), smoking (? = 0.22; p=0.009), lower NIHSS (? = -0.25; p=0.002) and history of coronary artery disease (? = 0.23; p=0,005) were associated with better rLMC score. Lower age (? = 0.29; p<0.001), lower NIHSS (? = 0.36; p<0.001) and rLMC>= 17 (? = -0.16; p=0.04) were associated with better functional outcomes. Conclusion: Patients with good leptomeningeal collateral flow had lower age, lower NIHSS, Chagas disease and history of smoking. Good leptomeningeal collaterals on CT angiography are associated to good outcome among AIS patients with proximal arterial occlusion of the anterior circulation in Brazil.

Ischemic brain injury causes neurodegeneration. In this study, the mechanism of neurodegeneration was investigated by examining the role of sterol regulatory element binding protein-1 (SREBP-1), CCAAT enhancer binding protein&amp / #946 / (C/EBP&amp / #946 / ), glutathione (GSH), malondialdehyde (MDA), glutathione-S-transferase (GST), and superoxide dismutase (SOD). Carotid artery occlusion (CAO) plus hypotension was produced for 10 minutes. Control groups were sham operated. Animals were sacrificed after 24 hours, 1 week, 2 and 4 weeks of reperfusion periods. The expression of C/EBP&amp / #946 / and SREBP-1 in rat brain cortex and cerebellum were examined by western blotting. C/EBP&amp / #946 / expressions significantly increased in both cytosolic (1.19, 1.58 fold) and nuclear (1.73, 1.81 fold) extracts of brain cortex at 24 hours and 1 week CAO groups, respectively. In cerebellum, C/EBP&amp / #946 / expression significantly increased in 1 week, cytosolic (1.63 fold), and nuclear (1.35 fold) extracts. SREBP-1 expression increased significantly in both cytosolic (2.07 fold) and nuclear (1.41 fold) extracts of brain cortex in 1 week. SREBP-1 expression significantly increased in cytosolic (2.15 fold) and nuclear (1.79 fold) extracts of cerebellum in 1 week. There were no significant alterations in SREBP-1 C/EBP&amp / #946 / expressions for 2 and 4 weeks in both cytosolic and nuclear extracts of brain cortex and cerebellum. There were insignificant changes in GSH and GST levels in cortex. However, MDA and SOD levels significantly increased by 43.0 % and 47.3 %, respectively, in 24 hours. Our findings indicate that increase in SREBP-1 and C/EBP&amp / #946 / expressions may be related to oxidative stress during ischemic neurodegenerative processes.

Background: To investigate whether vaccination against SARS-CoV-2 is associated with the onset of retinal vascular occlusive disease (RVOD). Methods: In this multicentre study, data from patients with central and branch retinal vein occlusion (CRVO and BRVO), central and branch retinal artery occlusion (CRAO and BRAO), and anterior ischaemic optic neuropathy (AION) were retrospectively collected during a 2-month index period (1 June–31 July 2021) according to a defined protocol. The relation to any previous vaccination was documented for the consecutive case series. Numbers of RVOD and COVID-19 vaccination were investigated in a case-by-case analysis. A case– control study using age- and sex-matched controls from the general population (study participants from the Gutenberg Health Study) and an adjusted conditional logistic regression analysis was conducted. Results: Four hundred and twenty-one subjects presenting during the index period (61 days) were enrolled: one hundred and twenty-one patients with CRVO, seventy-five with BRVO, fifty-six with CRAO, sixty-five with BRAO, and one hundred and four with AION. Three hundred and thirty-two (78.9%) patients had been vaccinated before the onset of RVOD. The vaccines given were BNT162b2/BioNTech/Pfizer (n = 221), followed by ChadOx1/AstraZeneca (n = 57), mRNA- 1273/Moderna (n = 21), and Ad26.COV2.S/Johnson & Johnson (n = 11; unknown n = 22). Our case–control analysis integrating population-based data from the GHS yielded no evidence of an increased risk after COVID-19 vaccination (OR = 0.93; 95% CI: 0.60–1.45, p = 0.75) in connection with a vaccination within a 4-week window. Conclusions: To date, there has been no evidence of any association between SARS-CoV-2 vaccination and a higher RVOD risk.

Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

No description available.